Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes.

about

A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving 1-2 Oral Anti-Diabetic Drugs.Systematic review of incretin therapy during peri-operative and intensive care

P2860

Q52575496-5AFECDF8-0204-450A-9C7F-F3A4999CE803 Q59126600-6CA111AE-8789-4F08-A23C-78BEC7257CCA

P2860

Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes.

Item

http://www.wikidata.org/entity/Q42371337

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Reasons for discontinuation of ...... patients with type 2 diabetes.

@en

Reasons for discontinuation of ...... patients with type 2 diabetes.

@nl

type

Item

label

Reasons for discontinuation of ...... patients with type 2 diabetes.

@en

Reasons for discontinuation of ...... patients with type 2 diabetes.

@nl

prefLabel

Reasons for discontinuation of ...... patients with type 2 diabetes.

@en

Reasons for discontinuation of ...... patients with type 2 diabetes.

@nl

P1476

Reasons for discontinuation of ...... patients with type 2 diabetes.

@en

P2093

Alan A Martin

http://www.w3.org/2001/XMLSchema#string

Andrea Leith

http://www.w3.org/2001/XMLSchema#string

James Piercy

http://www.w3.org/2001/XMLSchema#string

Mirko V Sikirica

http://www.w3.org/2001/XMLSchema#string

Robert Wood

http://www.w3.org/2001/XMLSchema#string

Victoria Higgins

http://www.w3.org/2001/XMLSchema#string

P2860

A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond

GLP-1 receptor agonists: a review of head-to-head clinical studies

Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes.

Evaluation of the consumer assessment of healthcare providers and systems in-center hemodialysis survey

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.

Glucagon-like Peptide-1 receptor agonist treatment patterns among type 2 diabetes patients in six European countries

Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme

Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015.

Beyond metformin: safety considerations in the decision-making process for selecting a second medication for type 2 diabetes management: reflections from a diabetes care editors' expert forum.

External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants?

P304

403-412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DMSO.S141235

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29033597

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

5630073

http://www.w3.org/2001/XMLSchema#string

Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes.

about

P2860

P2860

Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932